Fig. 1 · Structure
Documents & Downloads
Icosabutate
EPA Derivative
Icosabutate is an orally active derivative of eicosapentaenoic acid (EPA) that targets liver metabolism. It enhances insulin sensitivity and reduces hepatic inflammation and fibrosis, addressing limitations associated with unmodified EPA. Icosabutate has demonstrated efficacy in lowering non-high-density lipoprotein cholesterol (non-HDL-C) levels in cases of persistent hypertriglyceridemia, making it a valuable tool for research in lipid metabolism and related metabolic disorders.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 1253909-57-7 |
| Applications | EPA Derivative |
| Formula | C24H38O3 |
| Molecular Weight | 374.56 |
| SMILES | CCC(OCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)C(O)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.